Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 31Myelodysplastic Syndromes 26Multiple Myeloma 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Leukemia 19Lymphoma 18Hodgkin Disease 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Lymphoma, Non-Hodgkin 13Leukemia, Lymphocytic, Chronic, B-Cell 13Lymphoma, Large B-Cell, Diffuse 10Hematologic Neoplasms 9Primary Myelofibrosis 8Leukemia, Myelomonocytic, Chronic 8Graft vs Host Disease 8Myeloproliferative Disorders 7Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Leukemia, Myelomonocytic, Juvenile 5Recurrence 4Neoplasms 4Lymphoma, T-Cell 4Lymphoma, B-Cell, Marginal Zone 4Burkitt Lymphoma 4Breast Neoplasms 4Anemia, Aplastic 4Polycythemia Vera 3Lymphoma, Mantle-Cell 3Leukemia, Biphenotypic, Acute 3Hemoglobinuria, Paroxysmal 3

Interventions

Cyclophosphamide 18Etoposide 12Cisplatin 11Temozolomide 10Vincristine 9Radiotherapy 9Magnetic Resonance Spectroscopy 9Filgrastim 8Irinotecan 7Carboplatin 7X-Rays 6Phantoms, Imaging 6Topotecan 5Specimen Handling 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Thiotepa 4Radiation 4Lomustine 4Biopsy 4Bevacizumab 4tipifarnib 3sargramostim 3palbociclib 3Methotrexate 3HhAntag691 3Chemotherapy, Adjuvant 3ulixertinib 2tazemetostat 2sonidegib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Medulloblastoma × Stem Cell Transplantation × Clear all
NCT00179803 2020-08-05

Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 2 Completed
24 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Pinealoma, Supratentorial Neoplasms, Central Nervous System Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡